These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7890910)

  • 1. Chronic hepatitis B acquired in childhood: unanswered questions and evolving issues.
    Bortolotti F
    J Hepatol; 1994 Nov; 21(5):904-9. PubMed ID: 7890910
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon therapy in chronic hepatitis B and delta infection in children].
    Nisevich NI; Uchaĭkin VF; Sokolova NV; Kuznetsov VP; Syr'eva TN; Cherednichenko TV; Kaganov BS; Moleva TP; Iusuf-zade AA; Guseva LN
    Vestn Akad Med Nauk SSSR; 1991; (11):56-9. PubMed ID: 1767580
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful antiviral therapy and prognosis in cirrhosis due to hepatitis B.
    Han SB; Martin P
    Am J Gastroenterol; 1998 Jun; 93(6):859-60. PubMed ID: 9647008
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of quantitative measurement of HBeAg and HBsAg before interferon-alpha treatment of chronic hepatitis B in children.
    Burczynska B; Madalinski K; Pawlowska J; Woynarowski M; Socha J; Gerlich WH; Willems WR; Wozniewicz B; Stachowski J
    J Hepatol; 1994 Dec; 21(6):1097-102. PubMed ID: 7699234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
    Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
    Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis B in childhood].
    Calzia R; Marazzi MG; Bonura ML; Giovale M; Massacane R; Piscopo R; Santoni O; Zauli C; Navone C; Ciravegna B
    Minerva Pediatr; 1984 Jun; 36(12):605-9. PubMed ID: 6513895
    [No Abstract]   [Full Text] [Related]  

  • 7. Histologic changes in Chinese patients with chronic hepatitis B virus infection after interferon-alpha therapy.
    Wu PC; Lok AS; Lau JY; Lauder IJ; Lai CL
    Am J Clin Pathol; 1992 Oct; 98(4):402-7. PubMed ID: 1415022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B (acute and chronic)].
    Kolyvanos Naumann U; Käser L; Vetter W
    Praxis (Bern 1994); 2004 Jul; 93(31-32):1227-33; quiz 1234, 1261. PubMed ID: 15453144
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A prevalence survey of hepatitis B virus infection among Lisu national minorities].
    Liu ZL; Ye MJ; Bai JX; Yu Q; Wan CM; Wang J; Liu HC; Zhong SM; Qing SH
    Sichuan Yi Xue Yuan Xue Bao; 1985 Jun; 16(2):166-9. PubMed ID: 3837366
    [No Abstract]   [Full Text] [Related]  

  • 11. [The significance of studying the HBe system in the prognosis of patients with acute and chronic viral hepatitis Be].
    Perisić-Savić M; Nastić-Mirić D
    Srp Arh Celok Lek; 1983; 111(9-10):1343-50. PubMed ID: 6681452
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of HBsAg after interferon-alpha treatment: cure of chronic hepatitis B virus?
    Davis GL
    Hepatology; 1991 Nov; 14(5):953-4. PubMed ID: 1937401
    [No Abstract]   [Full Text] [Related]  

  • 13. [Seroepidemiology of hepatitis B in pediatric age. Studies conducted in the city of Rome].
    Mastroeni I; Vescia N; Pompa MG; Signorelli C
    Ann Ig; 1990; 2(1-2):15-9. PubMed ID: 1711334
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B infection in New Zealand children.
    Hermon YE; Mushahwar IK; Tobias MI
    N Z Med J; 1984 Dec; 97(770):887-9. PubMed ID: 6595574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elements with prognostic value in the chronic evolution of viral hepatitis. Markers of the evolution].
    Banciu T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):161-70. PubMed ID: 2875504
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial failure of hepatitis B immunization.
    del Rosario JF; Orenstein SR
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):307-11. PubMed ID: 8890083
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatitis B: serological strategy and epidemiological aspects].
    Penna R; Rabagliati AM
    G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
    [No Abstract]   [Full Text] [Related]  

  • 19. [Distribution of viral hepatitis B infection in Guangsi Province].
    Ding ZR
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Apr; 3(2):84-7. PubMed ID: 7185451
    [No Abstract]   [Full Text] [Related]  

  • 20. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon.
    Lisker-Melman M; Webb D; Di Bisceglie AM; Kassianides C; Martin P; Rustgi V; Waggoner JG; Park Y; Hoofnagle JH
    Ann Intern Med; 1989 Sep; 111(6):479-83. PubMed ID: 2774373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.